380 related articles for article (PubMed ID: 34071193)
1. How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.
Wessely A; Steeb T; Berking C; Heppt MV
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071193
[TBL] [Abstract][Full Text] [Related]
2. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.
Falletta P; Sanchez-Del-Campo L; Chauhan J; Effern M; Kenyon A; Kershaw CJ; Siddaway R; Lisle R; Freter R; Daniels MJ; Lu X; Tüting T; Middleton M; Buffa FM; Willis AE; Pavitt G; Ronai ZA; Sauka-Spengler T; Hölzel M; Goding CR
Genes Dev; 2017 Jan; 31(1):18-33. PubMed ID: 28096186
[TBL] [Abstract][Full Text] [Related]
3. Human melanocytes form a PAX3-expressing melanocyte cluster on Matrigel by the cell migration process.
Choi H; Jin SH; Han MH; Lee J; Ahn S; Seong M; Choi H; Han J; Cho EG; Lee TR; Noh M
J Dermatol Sci; 2014 Oct; 76(1):60-6. PubMed ID: 25128984
[TBL] [Abstract][Full Text] [Related]
4. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
[TBL] [Abstract][Full Text] [Related]
5. MSX1-Induced Neural Crest-Like Reprogramming Promotes Melanoma Progression.
Heppt MV; Wang JX; Hristova DM; Wei Z; Li L; Evans B; Beqiri M; Zaman S; Zhang J; Irmler M; Berking C; Besch R; Beckers J; Rauscher FJ; Sturm RA; Fisher DE; Herlyn M; Fukunaga-Kalabis M
J Invest Dermatol; 2018 Jan; 138(1):141-149. PubMed ID: 28927893
[TBL] [Abstract][Full Text] [Related]
6. Neural crest stem cells in melanoma development.
Shakhova O
Curr Opin Oncol; 2014 Mar; 26(2):215-21. PubMed ID: 24441506
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide stress responses in neural crest cell fate and melanoma.
Sporrij A; Zon LI
Cell Cycle; 2021 Aug; 20(15):1455-1467. PubMed ID: 34281491
[TBL] [Abstract][Full Text] [Related]
8. FOXD3 regulates the lineage switch between neural crest-derived glial cells and pigment cells by repressing MITF through a non-canonical mechanism.
Thomas AJ; Erickson CA
Development; 2009 Jun; 136(11):1849-58. PubMed ID: 19403660
[TBL] [Abstract][Full Text] [Related]
9. FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanoma.
Weiss MB; Abel EV; Dadpey N; Aplin AE
Mol Cancer Res; 2014 Sep; 12(9):1314-23. PubMed ID: 25061102
[TBL] [Abstract][Full Text] [Related]
10. Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma.
Capparelli C; Purwin TJ; Glasheen M; Caksa S; Tiago M; Wilski N; Pomante D; Rosenbaum S; Nguyen MQ; Cai W; Franco-Barraza J; Zheng R; Kumar G; Chervoneva I; Shimada A; Rebecca VW; Snook AE; Hookim K; Xu X; Cukierman E; Herlyn M; Aplin AE
Nat Commun; 2022 Mar; 13(1):1381. PubMed ID: 35296667
[TBL] [Abstract][Full Text] [Related]
11. Differential PAX3 functions in normal skin melanocytes and melanoma cells.
Medic S; Rizos H; Ziman M
Biochem Biophys Res Commun; 2011 Aug; 411(4):832-7. PubMed ID: 21802410
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma.
Muccioli S; Brillo V; Varanita T; Rossin F; Zaltron E; Velle A; Alessio G; Angi B; Severin F; Tosi A; D'Eletto M; Occhigrossi L; Falasca L; Checchetto V; Ciaccio R; Fascì A; Chieregato L; Rebelo AP; Giacomello M; Rosato A; Szabò I; Romualdi C; Piacentini M; Leanza L
Cell Death Dis; 2023 Oct; 14(10):704. PubMed ID: 37898636
[TBL] [Abstract][Full Text] [Related]
13. DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype.
Sanna A; Phung B; Mitra S; Lauss M; Choi J; Zhang T; Njauw CN; Cordero E; Harbst K; Rosengren F; Cabrita R; Johansson I; Isaksson K; Ingvar C; Carneiro A; Brown K; Tsao H; Andersson M; Pietras K; Jönsson G
JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36040798
[TBL] [Abstract][Full Text] [Related]
14. Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance.
Castro-Pérez E; Singh M; Sadangi S; Mela-Sánchez C; Setaluri V
Pigment Cell Melanoma Res; 2023 Sep; 36(5):330-347. PubMed ID: 37132530
[TBL] [Abstract][Full Text] [Related]
15. A novel stilbene-like compound that inhibits melanoma growth by regulating melanocyte differentiation and proliferation.
Stueven NA; Schlaeger NM; Monte AP; Hwang SL; Huang CC
Toxicol Appl Pharmacol; 2017 Dec; 337():30-38. PubMed ID: 29042215
[TBL] [Abstract][Full Text] [Related]
16. The gene regulatory basis of genetic compensation during neural crest induction.
Dooley CM; Wali N; Sealy IM; White RJ; Stemple DL; Collins JE; Busch-Nentwich EM
PLoS Genet; 2019 Jun; 15(6):e1008213. PubMed ID: 31199790
[TBL] [Abstract][Full Text] [Related]
17. Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.
Gershon TR; Oppenheimer O; Chin SS; Gerald WL
Neoplasia; 2005 Jun; 7(6):575-84. PubMed ID: 16036108
[TBL] [Abstract][Full Text] [Related]
18. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.
Su Z; Zheng X; Zhang X; Wang Y; Zhu S; Lu F; Qu J; Hou L
J Dermatol Sci; 2017 Mar; 85(3):216-225. PubMed ID: 27955842
[TBL] [Abstract][Full Text] [Related]
19. Beyond MITF: Multiple transcription factors directly regulate the cellular phenotype in melanocytes and melanoma.
Seberg HE; Van Otterloo E; Cornell RA
Pigment Cell Melanoma Res; 2017 Sep; 30(5):454-466. PubMed ID: 28649789
[TBL] [Abstract][Full Text] [Related]
20. Targeting invasive properties of melanoma cells.
Arozarena I; Wellbrock C
FEBS J; 2017 Jul; 284(14):2148-2162. PubMed ID: 28196297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]